Skip to main content

Meagan C. Fitzpatrick, PhD

Academic Title:

Assistant Professor

Primary Appointment:

Medicine

Phone (Primary):

(410) 706-8255

Education and Training

  • University of Notre Dame, B.S. in Biological Sciences, 2006
  • Yale University, Ph.D. in Epidemiology of Microbial Diseases, 2014
  • Postdoctoral Associate, Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, 2015-2016
  • Postdoctoral Fellow, Center for Vaccine Development, University of Maryland School of Medicine, 2016-2017

Biosketch

Dr. Fitzpatrick joined the faculty of the Center for Vaccine Development and Global Health (CVD) in 2017. She conducted her doctoral training at the Yale School of Public Health, with the Center for Infectious Disease Modeling and Analysis (CIDMA). Her research focuses primarily on the evaluation of infectious disease control strategies, with an emphasis on vaccination. Dr. Fitzpatrick develops dynamic transmission models to assess the efficiency and cost-effectiveness of these control policies, and applies optimization strategies to identify potential avenues for improvment. Furthermore, Dr. Fitzpatrick's work uses interdisciplinary methods to analyze how parameter uncertainty impacts the optimal decision.

Dr. Fitzpatrick is currently focusing on improving vaccination policies against rotavirus and pertussis. She has conducted research addressing a wide range of additional pathogens including rabies, influenza, HIV, Zika, and Ebola.

Research/Clinical Keywords

Infectious disease modeling; Transmission modeling; Dynamic modeling; Vaccine impact; Cost-effectiveness analysis; Medical decision-making; Pharmacoeconomics; Global health; One Health; Maternal vaccination; Neonatal vaccination; Rabies; Pertussis; Rotavirus; Influenza; Zika; Ebola

Highlighted Publications

Fitzpatrick, MC; Singer, BH; Hotez, PJ; Galvani, AP. (2017) Saving lives efficiently across sectors: The need for a Congressional cost-effectiveness committee. The Lancet. 6736(17): 17 – 19.

Fitzpatrick, MC; Shah, HA; Pandey, A; Bilinski, AM; Kakkar, M; Clark, AD; Townsend, JP; Abbas, SS; Galvani, AP. (2016) One Health approach to cost-effective rabies control in India. Proceedings of the National Academy of Sciences, USA. 113(51): 14574 – 14581.

Fitzpatrick, MC; Wenzel, NS; Scarpino, SV; Althouse, BM; Atkins, KE; Galvani, AP; Townsend, JP. (2016) Cost-effectiveness of next-generation vaccines: the case of pertussis. Vaccine. 34(29): 3405 – 3411.

Atkins, KE*; Fitzpatrick, MC*; Galvani, AP; Townsend, JP. (2016) Cost-effectiveness of pertussis vaccination during pregnancy in the US. American Journal of Epidemiology. 183(12): 1159 – 1170. *Authors contributed equally to this paper.

Fitzpatrick, MC; Hampson, K; Cleaveland, S; Mzimbiri, I; Lankester, F; Lembo, T; Meyers, LA; Paltiel, AD; Galvani, AP. (2014) Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Annals of Internal Medicine. 160(2): 91 – 100

Additional Publication Citations

Galvani, AP; Pandey, A; Fitzpatrick, MC; Medlock, J; Gray, GE. (2018) Defining control of HIV epidemics. The Lancet HIV. 5(11): 667 – 670.

Fitzpatrick, MC; Gray, GE; Galvani, AP. (2018) Facing the Future – the Challenge of Vanquishing HIV for the Next Generation. JAMA Pediatrics. 172(7): 609 – 610.

Sah, P; Medlock, J; Fitzpatrick, MC; Singer, BH; Galvani, AP. (2018) Optimizing the impact of low-efficacy influenza vaccines. Proceedings of the National Academy of Sciences, USA. 115(20): 5151 – 5156.

Durham, DP; Fitzpatrick, MC; Ndeffo-Mbah, ML; Parpia, MS; Michael, NL; Galvani, AP. (2018) Evaluating Zika vaccination strategies in the Americas. Annals of Internal Medicine. 168(9): 621 – 630.

Haidara, FC; Tapia, MD; Sow SO; Doumbia, M; Coulibaly, F; Diallo, F; Traoré, A; Kodio, M; Kelly, CL; Fitzpatrick, MC; Kotloff, K; Victor, JC; Neuzil, K. (2018) Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants. Journal of Infectious Diseases. 218(4): 606 – 613.

Fitzpatrick, MC; Singer, BH; Hotez, PJ; Galvani, AP. (2017) Saving lives efficiently across sectors: The need for a Congressional cost-effectiveness committee. The Lancet. 6736(17): 17 – 19.

Galvani, AP; Fitzpatrick, MC; Vermund, SH; Singer, BH. (2017) Fund global health: Save lives and money. Science. 356: 1018 – 9.

Sah, P; Fitzpatrick, MC; Pandey, A; Galvani, AP. (2017) HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the ‘Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.’ AIDS. 31(17): 2437 – 2439.

Galvani, AP; Durham DP; Vermund, SH; Fitzpatrick MC. (2017) California Universal Health Care: an economic stimulus and life-saving proposal. The Lancet. DOI:10.1016/S0140-6736(17)32148-7.

Fitzpatrick, MC; Shah, HA; Pandey, A; Bilinski, AM; Kakkar, M; Clark, AD; Townsend, JP; Abbas, SS; Galvani, AP. (2016) One Health approach to cost-effective rabies control in India. Proceedings of the National Academy of Sciences, USA. 113(51): 14574 – 14581.

Bilinski, AM; Fitzpatrick, MC; Rupprecht, CE; Paltiel, AD; Galvani, AP. (2016) Optimal frequency of rabies vaccination campaigns in sub-Saharan Africa. Proceedings of the Royal Society B. 283(1842): 20161211.

Fitzpatrick, MC; Wenzel, NS; Scarpino, SV; Althouse, BM; Atkins, KE; Galvani, AP; Townsend, JP. (2016) Cost-effectiveness of next-generation vaccines: the case of pertussis. Vaccine. 34(29): 3405 – 3411.

Atkins, KE*; Fitzpatrick, MC*; Galvani, AP; Townsend, JP. (2016) Cost-effectiveness of pertussis vaccination during pregnancy in the US. American Journal of Epidemiology. 183(12): 1159 – 1170. *Authors contributed equally to this paper.

DeAngelis, H; Scarpino, SV; Fitzpatrick, MC; Galvani, AP; Althouse, BM. (2016) Epidemiological and economic impacts of priming with whole-cell Bordetella pertussis vaccine. JAMA Pediatrics. 170(5): 459 – 65.

Alfaro-Murillo, JA*; Parpia, AS*; Fitzpatrick, MC*; Tamagnan, JA; Medlock, J; Ndeffo-Mbah, ML; Fish, D; Ávila-Agüero, ML; Marín, R; Ko, AI; Galvani, AP. (2016) A cost-effectiveness tool for informing policies on Zika virus control. PLoS Neglected Tropical Diseases. 10(5): e000473 *Authors contributed equally to this paper.

Fitzpatrick, MC; Hampson, K; Cleaveland, S; Mzimbiri, I; Lankester, F; Lembo, T; Meyers, LA; Paltiel, AD; Galvani, AP. (2014) Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Annals of Internal Medicine. 160(2): 91 – 100

Dunn, JM; Krause, PJ; Davis, S; Vannier, EG; Fitzpatrick, MC; Rollend, L; Belperron, AA; States, SL; Stacey A; Bockenstedt, LK; Fish, D; Diuk-Wasser, MA. (2014) Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States. PLoS ONE. 9(12): e115494

Fitzpatrick, MC; Hampson, K; Cleaveland, S; Meyers, LA; Townsend, JP; Galvani, AP. (2012) Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. PLoS Neglected Tropical Diseases. 6(8): e1796

Coulibaly, MB; Lobo, NF; Fitzpatrick, MC; Kern, M; Grushko, O; Thaner, DV; Traore, SF; Collins, FH; Besansky, NJ. (2007) Segmental duplication implicated in the genesis of inversion 2Rj of Anopheles gambiae. PLoS ONE. 2(9): e849

Stump, AD; Fitzpatrick, MC; Lobo, NF; Traore, S; Sagnon, NF; Costantini, C; Collins, FH; Besansky, NJ. (2005) Centromere-proximal differentiation and speciation in Anopheles gambiae. Proceedings of the National Academy of Sciences, USA. 102(44):15930 – 15935

Awards and Affiliations

Affiliate, Center for Infectious Disease Modeling and Analysis, Yale School of Public Health

Links of Interest

Google Scholar: https://scholar.google.com/citations?user=cCgEwiIAAAAJ&hl=en